Positive and Negative Affect Schedule (PANAS): psychometric properties of the online Spanish version in a clinical sample with emotional disorders.
Assessment
Emotional disorders
Online
Positive and negative affect
Psychometrics
Validation
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
10 02 2020
10 02 2020
Historique:
received:
28
06
2019
accepted:
30
01
2020
entrez:
11
2
2020
pubmed:
11
2
2020
medline:
17
12
2020
Statut:
epublish
Résumé
The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to assess positive and negative affect. The PANAS has been validated in several languages, and it has shown excellent psychometric properties in the general population and some clinical samples, such as forensic samples, substance users, and adult women with fibromyalgia. Nevertheless, the psychometric properties of the scale have not yet been examined in clinical samples with anxiety, depressive, and adjustment disorders. In addition, the proliferation of Internet-based treatments has led to the development of a wide range of assessments conducted online with digital versions of pen and paper self-report questionnaires. However, no validations have been carried out to analyze the psychometric properties of the online version of the PANAS. The present study investigates the psychometric properties of the online Spanish version of the PANAS in a clinical sample of individuals with emotional disorders. The sample was composed of 595 Spanish adult volunteers with a diagnosis of depressive disorder (n = 237), anxiety disorder (n = 284), or adjustment disorder (n = 74). Factor structure, construct validity, internal consistency, and sensitivity to change were analyzed. Confirmatory factor analysis yielded a latent structure of two independent factors, consistent with previous validations of the instrument. The analyses showed adequate convergent and discriminant validity, good internal consistency as well as sensitivity to change. Overall, the results obtained in this study show that the online version of the PANAS has adequate psychometric properties for the assessment of positive and negative affect in a Spanish clinical population.
Sections du résumé
BACKGROUND
The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to assess positive and negative affect. The PANAS has been validated in several languages, and it has shown excellent psychometric properties in the general population and some clinical samples, such as forensic samples, substance users, and adult women with fibromyalgia. Nevertheless, the psychometric properties of the scale have not yet been examined in clinical samples with anxiety, depressive, and adjustment disorders. In addition, the proliferation of Internet-based treatments has led to the development of a wide range of assessments conducted online with digital versions of pen and paper self-report questionnaires. However, no validations have been carried out to analyze the psychometric properties of the online version of the PANAS. The present study investigates the psychometric properties of the online Spanish version of the PANAS in a clinical sample of individuals with emotional disorders.
METHODS
The sample was composed of 595 Spanish adult volunteers with a diagnosis of depressive disorder (n = 237), anxiety disorder (n = 284), or adjustment disorder (n = 74). Factor structure, construct validity, internal consistency, and sensitivity to change were analyzed.
RESULTS
Confirmatory factor analysis yielded a latent structure of two independent factors, consistent with previous validations of the instrument. The analyses showed adequate convergent and discriminant validity, good internal consistency as well as sensitivity to change.
CONCLUSIONS
Overall, the results obtained in this study show that the online version of the PANAS has adequate psychometric properties for the assessment of positive and negative affect in a Spanish clinical population.
Identifiants
pubmed: 32039720
doi: 10.1186/s12888-020-2472-1
pii: 10.1186/s12888-020-2472-1
pmc: PMC7008531
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
56Subventions
Organisme : Ministerio de Economía y Competitividad
ID : BES-2015-072360
Pays : International
Références
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Psychol Assess. 2009 Sep;21(3):256-71
pubmed: 19719339
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
J Psychiatr Res. 2011 Feb;45(2):262-8
pubmed: 20609450
Neuropsychopharmacol Hung. 2011 Jun;13(2):73-9
pubmed: 21677320
J Affect Disord. 2013 Dec;151(3):942-9
pubmed: 24051099
Span J Psychol. 2008 Nov;11(2):626-40
pubmed: 18988448
Psychol Assess. 2011 Mar;23(1):215-25
pubmed: 21280952
Am J Drug Alcohol Abuse. 2016 Mar;42(2):203-12
pubmed: 26905228
BMC Psychiatry. 2015 May 07;15:106
pubmed: 25948287
Behav Res Ther. 2013 Nov;51(11):736-41
pubmed: 24076407
Qual Life Res. 1995 Aug;4(4):293-307
pubmed: 7550178
Clin Psychol Rev. 2010 Nov;30(7):839-48
pubmed: 19939530
J Med Internet Res. 2016 Aug 26;18(8):e231
pubmed: 27565118
Psychiatry Investig. 2010 Sep;7(3):163-9
pubmed: 20927304
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
Eur J Psychol Assess. 2003;19(2):131-141
pubmed: 20467578
J Med Internet Res. 2014 Dec 03;16(12):e268
pubmed: 25472463
Neuropsychiatr Dis Treat. 2017 Mar 31;13:987-1006
pubmed: 28408833
J Pers. 1992 Jun;60(2):441-76
pubmed: 1635050
Behav Res Methods. 2018 Oct;50(5):2057-2073
pubmed: 29052165
Span J Psychol. 2013;16:E58
pubmed: 24230921
BMC Psychiatry. 2016 Feb 25;16:45
pubmed: 26915661
Am Psychol. 2001 Mar;56(3):218-26
pubmed: 11315248
Psychol Bull. 1985 Sep;98(2):219-35
pubmed: 3901060
PLoS One. 2010 Oct 13;5(10):e13196
pubmed: 20967242
J Pak Med Assoc. 2017 Oct;67(10):1517-1523
pubmed: 28955067
Psychol Methods. 2002 Mar;7(1):105-25
pubmed: 11928886
PeerJ. 2016 Mar 24;4:e1822
pubmed: 27047704
PLoS One. 2017 Feb 27;12(2):e0172741
pubmed: 28241025
BMC Psychiatry. 2017 Apr 20;17(1):145
pubmed: 28424068
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
PLoS One. 2018 Nov 1;13(11):e0206516
pubmed: 30383797
Cogn Behav Ther. 2009;38(4):196-205
pubmed: 20183695
Med Care. 2006 Nov;44(11 Suppl 3):S50-9
pubmed: 17060836
BMC Psychiatry. 2018 May 31;18(1):161
pubmed: 29855281
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
BMC Psychiatry. 2017 Aug 9;17(1):291
pubmed: 28793892
Prev Sci. 2015 Oct;16(7):987-96
pubmed: 24752569
J Med Internet Res. 2007 Jan 31;9(1):e2
pubmed: 17478411
Annu Rev Clin Psychol. 2007;3:29-51
pubmed: 17716047